Why did GAAP EPS rise so much more than adjusted earnings, and which figure should investors rely on?

GAAP EPS of $2.78 includes after-tax items such as a $170M unrealized gain on fair value adjustments, mainly from derivatives and nuclear decommissioning trust investments. Adjusted Operating EPS of $1.82 strips these out and better reflects ongoing operations. Management uses adjusted earnings for guidance, so investors generally treat it as the primary measure of recurring performance, while recognizing that GAAP results can swing widely with market prices.

How much capital remains for share repurchases, and how does it fit the broader allocation plan?

The total repurchase authorization is $3 billion, with about $1.5 billion remaining after the April 2024 $1 billion increase. Management's February 2024 capital allocation slide showed about $2.3 billion of capital still to be allocated across 2024–2025, after dividends, identified growth investment, and buybacks. The company has also used an accelerated share repurchase agreement, with final delivery of shares expected in May 2024.

What is the nuclear production tax credit (PTC), and how does it affect earnings?

The nuclear PTC, created under the Inflation Reduction Act, provides up to $15 per MWh for qualifying nuclear output. It phases out as gross receipts rise from $25 to $43.75 per MWh, so the credit cushions earnings when power prices are low and fades when prices are high. Management says the PTC is in effect through 2032 and expects its value to grow with inflation, which underpins the company's base earnings outlook.

Why does the first quarter's green bond matter for Constellation?

The $900M, 30-year green senior notes are designed to finance green projects, including nuclear uprates that increase clean output at existing plants. Management cites it as the first U.S. corporate green bond that can fund nuclear energy. It supports the company's sustainability positioning and, alongside the Moody's upgrade, indicates confidence in its ability to fund growth while keeping credit metrics strong.

Are the 2024 guidance and long-term growth targets at risk?

Management reaffirmed 2024 guidance and targeted at least 10% annual adjusted earnings growth from 2024 through 2028, though growth may vary by year. Results depend on commodity prices, nuclear outage timing, PTC inflation, and commercial margins. The filing also includes extensive forward-looking statement caveats and cites risk factors in the 2023 Form 10-K and Q1 2024 Form 10-Q, so investors should weigh these uncertainties against the company's stated assumptions.

CEG 8-K: Earnings & Results & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed May 9, 2024. Cited figures are marked; the original filing is the authoritative source.

Constellation Energy (CEG) reported first-quarter 2024 results with GAAP net income of $883 million^a, or $2.78 per diluted share, up sharply from $0.29 per share in Q1 2023.

Adjusted (non-GAAP) Operating Earnings were $579 million^b, or $1.82 per share, versus $0.78 per share a year earlier. The improvement was driven by favorable market and portfolio conditions, the first quarter of nuclear production tax credits (PTCs), higher nuclear output, and lower refueling-outage costs, partly offset by lower zero-emission credit (ZEC) and capacity revenues and higher labor, contracting, and materials costs. GAAP operating revenues fell to $6.16 billion from $7.57 billion, largely because of lower commodity prices, but GAAP net income was lifted by a $170 million after-tax unrealized gain on fair value adjustments and other non-operating items.

Management reaffirmed full-year 2024 Adjusted Operating Earnings guidance of $7.23 to $8.03^c per share. Capital allocation was a major theme: the board authorized an additional $1 billion of share repurchases in April 2024, bringing the total program to $3 billion with roughly $1.5 billion remaining, and the company deployed about $500 million on buybacks in the quarter. Moody's upgraded the company's issuer rating to Baa1 from Baa2 with a stable outlook, and Constellation issued a $900 million 30-year green bond, described as the first U.S. corporate green bond that can fund nuclear projects.

Investors should note that GAAP results are volatile because of mark-to-market and decommissioning-trust accounting, so the gap between GAAP and adjusted earnings can be large in any quarter. Management's long-term outlook calls for at least 10% adjusted operating earnings growth from 2024 through 2028, supported by nuclear PTC inflation, attribute payments for carbon-free power, and share repurchases. Nuclear PTCs phase out between $25^d and $43.75 per MWh of revenue, so the value of that support depends on power prices.

02—Key points

Key Highlights

GAAP net income rose to $2.78 per diluted share ($883M) from $0.29 ($96M) in Q1 2023, while Adjusted Operating Earnings rose to $1.82 per share ($579M) from $0.78 ($256M).
Full-year 2024 Adjusted Operating Earnings guidance of $7.23–$8.03 per share was reaffirmed.
The board authorized an additional $1 billion for share repurchases in April 2024, bringing the program to $3 billion with about $1.5 billion remaining; about $500M was deployed in Q1 2024 and about $1.5B cumulatively since 2023.
Moody's upgraded the issuer rating to Baa1 from Baa2 with a stable outlook; S&P's rating is BBB+ with a stable outlook.
Constellation issued a $900M 30-year green bond, described as the first U.S. corporate green bond that can finance nuclear projects.
Nuclear generation rose to 45,391 GWh from 42,463 GWh, and the nuclear capacity factor (excluding Salem and STP) was 93.3%, versus 92.8% a year earlier.
GAAP operating revenues declined to $6.16B from $7.57B, and purchased power and fuel costs fell sharply, reflecting lower commodity prices year over year.

03—Questions

Frequently Asked Questions

Why did GAAP EPS rise so much more than adjusted earnings, and which figure should investors rely on?
GAAP EPS of $2.78 includes after-tax items such as a $170M unrealized gain on fair value adjustments, mainly from derivatives and nuclear decommissioning trust investments. Adjusted Operating EPS of $1.82 strips these out and better reflects ongoing operations. Management uses adjusted earnings for guidance, so investors generally treat it as the primary measure of recurring performance, while recognizing that GAAP results can swing widely with market prices.
How much capital remains for share repurchases, and how does it fit the broader allocation plan?
The total repurchase authorization is $3 billion, with about $1.5 billion remaining after the April 2024 $1 billion increase. Management's February 2024 capital allocation slide showed about $2.3 billion of capital still to be allocated across 2024–2025, after dividends, identified growth investment, and buybacks. The company has also used an accelerated share repurchase agreement, with final delivery of shares expected in May 2024.
What is the nuclear production tax credit (PTC), and how does it affect earnings?
The nuclear PTC, created under the Inflation Reduction Act, provides up to $15 per MWh for qualifying nuclear output. It phases out as gross receipts rise from $25 to $43.75 per MWh, so the credit cushions earnings when power prices are low and fades when prices are high. Management says the PTC is in effect through 2032 and expects its value to grow with inflation, which underpins the company's base earnings outlook.
Why does the first quarter's green bond matter for Constellation?
The $900M, 30-year green senior notes are designed to finance green projects, including nuclear uprates that increase clean output at existing plants. Management cites it as the first U.S. corporate green bond that can fund nuclear energy. It supports the company's sustainability positioning and, alongside the Moody's upgrade, indicates confidence in its ability to fund growth while keeping credit metrics strong.
Are the 2024 guidance and long-term growth targets at risk?
Management reaffirmed 2024 guidance and targeted at least 10% annual adjusted earnings growth from 2024 through 2028, though growth may vary by year. Results depend on commodity prices, nuclear outage timing, PTC inflation, and commercial margins. The filing also includes extensive forward-looking statement caveats and cites risk factors in the 2023 Form 10-K and Q1 2024 Form 10-Q, so investors should weigh these uncertainties against the company's stated assumptions.

04—Continue

← View all 8-K filings